3222-61-5

Upstream product

• 4949-44-4 ethyl propanoylacetate 
• 7664-41-7 ammonia 
• 64-17-5 ethanol 
• 77570-18-4 5-(1-Amino-propylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 
• 925-90-6 ethylmagnesium bromide 
• 105-56-6 ethyl 2-cyanoacetate 

Downstream Products

• 1151643-06-9 diethyl 4-(4,9-dimethoxy-5-oxo-5H-furo[3,2-g]chromen-6-yl)-2-ethyl-6-phenyl-1,4-dihydropyridine-3,5-dicarboxylate 
• 22192-02-5 ethyl 1,4-dihydro-2,6-dimethyl-4-oxopyridine-3-carboxylate 
• 334932-37-5 [2,6-Diethyl-5-((Z)-pent-1-enyl)-4-phenyl-pyridin-3-yl]-methanol 
• 202853-32-5 2,6-diethyl-3-hydroxymethyl-4-phenyl-5-(1-ethenyl)pyridine 
• 343335-40-0 ethyl (S)-3-acetamidopentanoate 
• 58051-17-5 2,6-Diethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester 
• 412324-02-8 6-ethyl-3-methyl-pyridine-2,4-diol 
• 100141-64-8 2,6-diethyl-4-chloro-nicotinic acid ethyl ester 

Relevant academic research and scientific papers

Synthesis of oxazolidin-2-ones and imidazolidin-2-ones directly from 1,3-diols or 3-amino alcohols using iodobenzene dichloride and sodium azide

A general and efficient method for the synthesis of oxazolidin-2-ones and imidazolidin-2-ones directly from 1,3-diols and 3-amino alcohols has been developed using the same reagent combination of iodobenzene dichloride (PhICl2) and sodium azide (NaN3).

Discovery of 5-Hydroxyalkyl-4-phenylpyridines as a new class of glucagon receptor antagonists

5-Hydroxyalkyl-4-phenylpyridines have been identified as a novel class of glucagon antagonists with potential utility for the treatment of diabetes. A lead structure with moderate activity was discovered through a high throughput screening assay. Structure-activity relationships led to the discovery of a potent antagonist, IC50=0.11 μM, more than 60-fold improvement over the lead structure.

Rh(I)-catalyzed enantioselective hydrogenation of (E)- and (Z)-beta-(acylamino)acrylates using 1,4-bisphosphine ligands under mild conditions.

[reaction: see text] Rh-Me-BDPMI (1a) complex can be an effective catalyst for the hydrogenations of (E)- and (Z)-beta-(acylamino)acrylates, in which the Z-isomers hydrogenated with the same or even higher ee values than the corresponding E-isomers. The conversion yield and enantioselectivity of E- and Z-isomers were largely dependent on the solvent, and thus, the E-isomers were hydrogenated more effectively in CH(2)Cl(2), whereas the Z-isomers were hydrogenated more effectively in polar MeOH solvent.